SCHEMBL790192

SCHEMBL790192

CC(=O)C(=O)OC(C)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL822892 0.79
SCHEMBL230054 0.77
SCHEMBL4611078 0.77
SCHEMBL4611710 0.77
SCHEMBL427360 0.77
SCHEMBL29034781 0.74
SCHEMBL8901753 0.74 TSHR (0.31)
Trimethylammonium SCHEMBL10802051 0.74 TSHR (0.42)
SCHEMBL291550 0.73 TSHR (0.38)
SCHEMBL9129538 0.72 TSHR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0667346-A2 Azole antifungal agents, process for the preparation there of and intermediates Eisai Co., Ltd. (JP) 1995-08-16 EP claimed
CN-122080417-A Cast-in-place concrete hydration heat optimal control method for lock mass concrete structure 2026-05-26 CN disclosed
CN-109071526-B Acid addition salts of piperazine derivatives 阿森纽荣股份公司 2023-02-28 CN disclosed
CN-111138402-B Preparation method of isocoumarin derivative 苏州大学 2021-11-23 CN disclosed
CN-108218809-B Synthetic method of medicine intermediate 2-aminothiazole-4-ethyl formate 宁夏法安德药业有限公司 2021-03-26 CN disclosed
CN-111138402-A Preparation method of isocoumarin derivative 苏州大学 2020-05-12 CN disclosed
US-10004730-B2 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2018-06-26 US disclosed
US-9981974-B2 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2018-05-29 US disclosed
US-20170246164-A1 SMALL MOLECULES TARGETING ANDROGEN RECEPTOR NUCLEAR LOCALIZATION AND/OR LEVEL IN PROSTATE CANCER UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2017-08-31 US disclosed
US-20170247382-A1 SMALL MOLECULES TARGETING ANDROGEN RECEPTOR NUCLEAR LOCALIZATION AND/OR LEVEL IN PROSTATE CANCER UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2017-08-31 US disclosed
EP-1250334-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2002-10-23 EP disclosed
EP-1242420-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2002-09-25 EP disclosed
EP-1231210-A2 Azole antifungal agents, processes for the preparation thereof, and intermediates Eisai Co., Ltd. (JP) 2002-08-14 EP disclosed
WO-2001044235-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2001-06-21 WO disclosed
WO-2001044247-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2001-06-21 WO disclosed
CN-1226555-A Antifungal agent, and preparation method and intermediate thereof 1999-08-25 CN disclosed
US-5792781-A EFFECTIVE AGAINST DERMATOMYCOSIS/VISCEROMYCOSIS CAUSED BY FUNGI, I.E., CANDIDA ALBICANS EISAI CO., LTD. (JP) 1998-08-11 US disclosed
US-5789429-A FUNGICIDE EISAI CO., LTD. (JP) 1998-08-04 US disclosed
US-5648372-A TRIAZOLES EISAI CO., LTD. (JP) 1997-07-15 US disclosed
EP-0667346-A2 Azole antifungal agents, process for the preparation there of and intermediates Eisai Co., Ltd. (JP) 1995-08-16 EP disclosed